In a recent newsletter, Joseph Arcangelo, the Co-Founder and Managing Partner of inSeption Group, speaks to the importance of establishing effective communication with potential development partners and how CMOs can develop trust between the service provider and biotech team members. You can view this piece in our newsletter here.
In the CMO Summit 360 Newsletter, Arcangelo discusses biotech outsourcing solutions and relationship management with service providers in clinical trials. He answers typical questions related to communication and negotiation between CMOs and service providers and stresses the importance of early discussions in negotiations, how to deal with the aggressive timelines of newer biotech companies, and the importance of focusing on even the little details when developing trust between parties.
“It is important the CMO is included in creating tangible and collaborative goals, objectives, and KPIs with your service provider for the clinical trial. When you can embed and integrate the right people, the discussion of the realities of any project becomes a joint effort among credible experts. And frequently, when that occurs, a phenomenon of what was seemingly impossible to consider actually gets completed within the preferred timeline.”
Ultimately, the CMO Summit 360 Newsletter article emphasizes the importance of developing trust in working with service providers on a clinical trial and the need for goal-oriented and effective communication between CMOs and service providers. We hope you’ll take the time to read the piece, and feel free to reach out to us to find out more about our services.